Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Company Description

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity.

The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity.

Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas.

As of February 27, 2020, it had three company-managed retail treatment centers in California.

Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Obalon Therapeutics Inc.
Obalon Therapeutics Inc. logo
Country United States
IPO Date Oct 6, 2016
Industry Medical - Devices
Sector Healthcare
Employees 2
CEO Kelly Huang

Contact Details

Address:
5421 Avenida Encinas Ste F
Carlsbad, California
United States
Website http://www.obalon.com

Stock Details

Ticker Symbol OBLN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001427570
CUSIP Number 67424L209
ISIN Number US67424L2097
Employer ID 00-0000000
SIC Code 3841

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
Jul 03, 2025 8-K Current Report
Jun 26, 2025 425 Filing
Jun 24, 2025 424B3 Filing
Jun 18, 2025 8-K Current Report
Jun 17, 2025 POS AM Filing
Jun 13, 2025 SCHEDULE 13G Filing
Jun 12, 2025 8-K Current Report
Jun 09, 2025 424B5 Filing
Jun 09, 2025 8-K Current Report
Jun 06, 2025 424B3 Filing